S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Albireo PharmaEmisphere TechnologiesChinook TherapeuticsFoghorn TherapeuticsEagle Pharmaceuticals
SymbolNASDAQ:ALBOOTCMKTS:EMISNASDAQ:KDNYNASDAQ:FHTXNASDAQ:EGRX
Price Information
Current Price$34.86$7.81$16.54$16.46$44.50
52 Week RangeBuyN/ABuyBuyBuy
MarketRank™
Overall Score1.50.91.61.51.5
Analysis Score3.50.03.53.52.3
Community Score2.42.62.83.32.9
Dividend Score0.00.00.00.00.0
Ownership Score1.71.70.80.01.7
Earnings & Valuation Score0.00.00.60.60.6
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$69.43N/A$30.33$25.00$52.50
% Upside from Price Target99.16% upsideN/A83.39% upside51.88% upside17.98% upside
Trade Information
Market Cap$665.02 million$673.08 million$697.29 million$589.50 million$579.84 million
Beta1.621.380.26N/A0.74
Average Volume184,08975,743100,24296,103117,542
Sales & Book Value
Annual Revenue$9.64 millionN/A$17.26 millionN/A$195.89 million
Price / Sales68.99N/A40.40N/A2.96
CashflowN/AN/AN/AN/A$1.62 per share
Price / CashN/AN/AN/AN/A27.49
Book Value$7.34 per shareN/A$4.07 per shareN/A$13.11 per share
Price / Book4.75N/A4.06N/A3.39
Profitability
Net Income$-62,720,000.00N/A$-82,370,000.00N/A$14.31 million
EPS($5.04)N/A($5.15)N/A$1.38
Trailing P/E RatioN/A0.00N/A0.00127.15
Forward P/E RatioN/AN/AN/A148.33
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-751.53%N/A-215.80%N/A2.65%
Return on Equity (ROE)-71.22%N/A-112.72%N/A8.50%
Return on Assets (ROA)-42.91%N/A-21.36%N/A5.44%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.04%N/AN/AN/A0.16%
Current Ratio13.52%N/A11.27%N/A3.60%
Quick Ratio13.51%N/A11.27%N/A3.45%
Ownership Information
Institutional Ownership Percentage85.65%0.02%N/AN/A95.12%
Insider Ownership Percentage5.00%72.90%5.90%N/A21.10%
Miscellaneous
Employees5564385108
Shares Outstanding19.08 million86.18 million42.16 million35.81 million13.03 million
Next Earnings Date5/6/2021 (Estimated)N/A3/8/2021 (Estimated)3/5/2021 (Estimated)3/2/2021 (Confirmed)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.